Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan for the Prevention of Peptic Ulcer Disease in Patients on Continuous Long-term Treatment With NSAIDs
NCT04840550Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- May 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in Peptic ulcer disease (PUD), sponsored by HK inno.N Corporation. Started May 2021; status: completed.
02
Drugs
tegoprazan
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT04840550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840550.